Description
An inhibitor of amyloid-β aggregation; inhibits aggregation of monomeric Aβ42 and induces disaggregation of Aβ42 fibrils in vitro from 3.1-50 µM; reduces Aβ42-induced toxicity in HT22 cells at 10 µM; increases step-through latency in a passive avoidance test and increases spontaneous alteration in the Y-maze compared with vehicle control mice in a mouse model of Aβ42-induced acute Alzheimer’s disease at 10 mg/kg; decreases brain levels of Aβ42 and increases spontaneous alteration in the Y-maze in the APP/PS1 transgenic mouse model of Alzheimer’s disease
Formal name: 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)-benzofuran
Synonyms: MDR-1339,
Molecular weight: 326.4
CAS: 1018946-38-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease